I think you are wrong. A surgeon like Ashkan and Liau may or may not have a financial interest but they continue to use the vaccine. I know Liau is not allowing to own stock but UCLA will profit with success. They believe it works and can prolong life. They use the product and they would survive just fine financially if they decided not to use it.
Not much else to it. They use the product because it works.
This is a lie: The company has told investors that they are still currently shopping for a publication. The last clear statement, made to one of the MB investors, was the article had been submitted. for peer review.
2 years is not a whopping amount of time to publish a manuscript. It has taken me 2 years a bunch of times and that was for nonsense research as compared to this. Nice try.
News 
Market Data 
Discover 
AI
